about
Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practiceFetal Alcohol Spectrum Disorder (FASD): neurobehavioral profile, indications for diagnosis and treatmentAssociation between positivity and smoking cessation.Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools.Acute alcoholic hepatitis.PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.Maternal risk factors for fetal alcohol spectrum disorders in a province in Italy.Neuropsychological characteristics of Italian children with fetal alcohol spectrum disorders.Former Heroin-Dependent Alcohol Use Disorder Patients. Prevalence, Addiction History and Clinical Features.[Gambling Disorder: epidemiology, diagnosis, interpretative models and intervention].Women, alcohol and the environment: an update and perspectives in neuroscience.Affective temperaments in alcoholic patients.Early exposure to ethanol but not red wine at the same alcohol concentration induces behavioral and brain neurotrophin alterations in young and adult mice.Early exposure to ethanol or red wine and long-lasting effects in aged mice. A study on nerve growth factor, brain-derived neurotrophic factor, hepatocyte growth factor, and vascular endothelial growth factor.[The nurse's role in the identification and management of alcohol abuser in the Emergency Department]Simultaneous liquid chromatographic assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics.[Alcohol and women: clinical aspects].[Arneth's formula and mean erythrocyte volume in chronic alcoholism]MRI and muscle signal intensities in alcoholics compared with control subjects.Hepatocyte growth factor, vascular endothelial growth factor, glial cell-derived neurotrophic factor and nerve growth factor are differentially affected by early chronic ethanol or red wine intake.Are children born to light drinkers not at high risk of developing clinically relevant cognitive-behavioural problems? A response to Kelly et al.[High-dose reduced glutathione in the therapy of alcoholic hepatopathy]Erythrocyte thiamine (Th) esters: a major factor of the alcohol withdrawal syndrome or a candidate marker for alcoholism itself?Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol.Blood thiamine, zinc, selenium, lead and oxidative stress in a population of male and female alcoholics: clinical evidence and gender differences.Avoidance coping strategies, alexithymia and alcohol abuse: a mediation analysis.Deep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation. A pilot study.Effects of olive leaf polyphenols on male mouse brain NGF, BDNF and their receptors TrkA, TrkB and p75.DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy.TNF-α and IL-10 modulation induced by polyphenols extracted by olive pomace in a mouse model of paw inflammation.[Esterification of cholesterol in patients with renal transplants. Determination of lecithin:cholesterol-acyl-transferase (LCAT) activity][Clinical experience with a new pharmaceutical formulation of cisapride in patients with functional dyspepsia]Subchronic oral toxicity of 4-chloro-alpha, alpha, alpha-trifluorotoluene in Sprague-Dawley ratsLecithin: cholesterol-acyltransferase (LCAT) activity in alcoholic liver diseaseHeparin effects on lipid metabolism in healthy peopleKetanserin hypertension and chronic alcoholism DB study in 40 patientsKetanserin (S2-receptor blocking agent), platelet activity and chronic alcoholismKetanserin, hypertension, and chronic alcoholism: double-blind study in forty patientsImpairment of lecithin:cholesterol acyltransferase (LCAT) activity in hemodialyzed subjects. I. No evidence of plasma LCAT-inhibiting factorsLecithin: cholesterol acyltransferase (LCAT) activity in long-term hemodialyzed subjects
P50
Q26995137-A7F17DBB-6280-46E7-920D-486E5DE2CE52Q28303743-0476100F-AA0D-4C10-938D-90ABD935CBAEQ33745582-45DBCE3A-537E-4E92-85AE-7C72AFCE3DA1Q33998936-48E8B75D-2093-4761-A991-26AD65B00AAEQ34571009-9DB224E4-E9F5-4349-8F98-02426BD0C9CFQ34693476-6FFA8D27-EB91-46ED-A93A-F6E0D020E488Q36531416-34B0B873-BFD5-46D9-A624-FC25BBAF0B19Q36986575-854F5CF5-87E5-4168-B54F-C574DC081E86Q38397965-ADDE5E7A-B2F2-4364-AA1E-4C28A68B1DB1Q41196635-878CEA26-E5C0-4707-9055-FBADFC99F8FAQ43272441-B9651263-1344-455E-9F53-501C8F9F5E4BQ43293934-9564232C-34DF-4AC2-A1E5-AB1111B5F6ABQ43936665-C3B3B196-8EA5-4EE7-8349-F54798730A58Q43974079-EB6D2BED-7E78-4262-944A-4E421EA05A44Q44367794-59669198-5D92-468D-A2D8-47D9F199941BQ44437690-9EFEDDE6-18CC-403E-92C0-80BCEE446F9BQ44989878-DF6D7751-A68B-48B9-B8D1-E3850A5A6941Q45021433-7194473B-5422-430D-BEAB-0A71255EA52AQ45193998-646C2F2B-0E38-4CF3-943F-FD458740A5D7Q46034855-02356D17-B2A3-4066-B3A9-2F80BEF2606CQ46135213-23AB1EC3-1204-401D-A861-1F33A4320567Q46441509-CEC892C6-48A9-497D-8075-F9499116D2FCQ46455210-DE0BFA08-C722-46D6-998B-08A95EFBDEFBQ46599165-70D4FBD3-A6EF-4248-B736-DB9A65CD021BQ46621697-DED8B496-C388-481F-A512-67C5CF73166AQ47584881-315FAABC-B218-4109-A4E8-0A3265953469Q48302028-E4C2A243-6177-4BDB-B290-577F0049A3E9Q48764260-65A8A093-162E-4B7D-BB35-BA95699172FDQ52301002-EA8C63A5-6740-4FA5-94DD-69F2B331259DQ53640790-87832A95-E767-45BD-8086-BE91FB928C34Q67259896-979AC389-DABE-46B4-AEF4-FB15A0F3E956Q68717501-4F2196CD-4B8F-4DA1-A738-90ACA69C79E8Q69445835-2AB540FD-94C4-4617-B18D-379FE4955DDEQ69618787-4D87422B-AAE4-48BD-8B21-1CCF508684E7Q69789131-07CF0E73-3DC8-4911-82F5-E00AEB10E4FAQ69985129-2502F101-9E12-4732-8B51-47BA5897ACEEQ69991051-9A43DF98-45D7-4EDE-97F9-2E55D71D5FEDQ70249632-41A86852-CE27-4E1F-8EE9-F86A9FA09FAAQ70628540-87FC5B3D-E584-42A4-A0FE-1C80B68C1786Q70742230-38B01D67-6AAA-4E1A-9332-EAE3CE3B79F3
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9981-8715
@en
name
Mauro Ceccanti
@ast
Mauro Ceccanti
@en
Mauro Ceccanti
@es
Mauro Ceccanti
@nl
type
label
Mauro Ceccanti
@ast
Mauro Ceccanti
@en
Mauro Ceccanti
@es
Mauro Ceccanti
@nl
altLabel
Mauro CECCANTI
@en
prefLabel
Mauro Ceccanti
@ast
Mauro Ceccanti
@en
Mauro Ceccanti
@es
Mauro Ceccanti
@nl
P106
P31
P496
0000-0001-9981-8715